US Drug Recall Register
Class III · Low risk Terminated Initiated Jun 3, 2016 (10 years ago)

Sirolimus Tablets

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed impurities/degradation: out of specification result for impurity secorapamycin.

What was recalled

Sirolimus Tablets, 1 mg, 100-count bottle, Rx only, Manufactured by: Dr. Reddy's Laboratories Limited, Visakhapatnam - 5300046 India, NDC 55111-653-01

Recalling firm
Dr. Reddy's Laboratories, Inc.
NDC code
55111-653-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1063-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Sirolimus recalls

See all
Class III · Low risk Terminated

Fyarro

Reason Failed Stability Specifications

Aadi Bioscience NDC 80803-153-50 D-0059-2023
Class III · Low risk Terminated

Sirolimus Oral Solution

Reason Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint.

Apotex Corp. NDC 60505-6197-2 D-0881-2022
Class III · Low risk Terminated

Sirolimus Tablets 1 mg

Reason Failed Impurities/Degradation Specifications

American Health Packaging NDC 68084-915-25 D-0813-2021
Class III · Low risk Terminated

TORISEL Kit

Reason Crystallization: Impurities in a raw material used to manufacture the diluent can cause the formation of crystals in the diluent vials after cold storage. The TORISEL vials are not affected by this issue.

Pfizer Inc. NDC 0008-1179-01 D-0235-2015